Compare Stocks

Back to Screener

Select Stocks to Compare

Add or remove up to 5 stocks to perform stock analysis, comparing market price, stock performance, and financial statements for informed decisions.

Stock Comparison Charts

Metric
Divi's Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Unichem Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Natural Capsules Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Sun Pharma Advanced Research Company Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Stock Details
Current Price 6930.0 603.55 219.72 159.32
Previous Close 6876.0 584.2 219.61 159.3
Open 6880.0 586.2 224.0 159.3
Day Low 6870.0 586.2 218.71 158.4
Day High 6939.5 615.0 224.0 159.8
Market Cap 1839700115456.0 42493419520.0 2272168448.0 51702845440.0
P/E Ratio 84.19 30.97 998.73 N/A
Forward P/E 123.09 N/A N/A 2.88
Earnings Per Share 82.31 19.49 0.22 -10.56
Dividend Yield (%) 0.44 N/A N/A N/A
Beta 0.34 0.07 -0.18 0.41
EBITDA 29680001024.0 2648600064.0 175184000.0 -3231399936.0
Book Value 563.71 347.9 58.16 -6.68
Debt to Equity 0.03 18.76 40.91 N/A
ROCE (%) N/A N/A N/A N/A
ROE (%) N/A N/A N/A N/A
Face Value N/A N/A N/A N/A
Price to Book 12.29 1.73 3.78 -23.85
Performance
1Y Return (%) 4851.93 949.3 -1199.76 -3664.24
About Company
Founded Year N/A N/A N/A N/A
Employees N/A N/A N/A N/A
Website Live Website of DIVISLAB Live Website of UNICHEMLAB Live Website of NATCAPSUQ Live Website of SPARC

Company Overviews & Financial Position

Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.

Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Unichem Laboratories Limited

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.

Natural Capsules Limited

Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. The company also exports its products. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.